BRIEF published on 09/23/2025 at 10:05, 9 months 13 days ago HeartBeat.bio Collaborates with Boehringer Ingelheim on Gene Therapies Cardiovascular Health Research Collaboration Gene Therapies Heart Muscle Disorders Cardioid Platform
BRIEF published on 09/23/2025 at 10:05, 9 months 13 days ago HeartBeat.bio collabore avec Boehringer Ingelheim sur les thérapies géniques Santé Cardiovasculaire Collaboration En Recherche Thérapies Géniques Troubles Du Muscle Cardiaque Plateforme Cardioïde
PRESS RELEASE published on 09/23/2025 at 10:00, 9 months 13 days ago HeartBeat.bio Joins Forces with Boehringer Ingelheim to Advance Gene Therapies for Inherited Heart Muscle Disorders HeartBeat.bio collaborates with Boehringer Ingelheim to develop gene therapies for genetic cardiomyopathies, addressing unmet needs in heart health Heart Health Gene Therapy Boehringer Ingelheim HeartBeat.bio Cardiomyopathies
PRESS RELEASE published on 11/02/2023 at 11:00, 2 years 8 months ago HeartBeat.bio raises € 4.5 million in Pre-Series A financing to drive development of organoid screening platform for cardiac drug discovery
Published on 07/06/2026 at 19:25, 3 hours 32 minutes ago Critical Elements Provides an Update on Its 10,000-Meter Summer Drill Program at Rose West
Published on 07/06/2026 at 19:25, 3 hours 32 minutes ago Critical Elements Fait Le Point Sur Programme De Forage Estival De 10 000 Mètres À Rose Ouest
Published on 07/06/2026 at 17:00, 5 hours 57 minutes ago PPX Mining Reports Second Consecutive Monthly Historical Record of Net Profit Interest Earned at Callanquitas Mine
Published on 07/06/2026 at 14:30, 8 hours 27 minutes ago As the Ebola Epidemic Spreads, NanoViricides Advances Towards a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo
Published on 07/06/2026 at 14:15, 8 hours 42 minutes ago Gold Terra Announces C$9.7 Million Life Offering, Including Participation From Strategic Shareholder David Harquail
Published on 07/06/2026 at 22:05, 52 minutes ago Abivax annonce la réalisation de son offre au public de 920 millions de dollars
Published on 07/06/2026 at 22:05, 52 minutes ago Abivax Announces Closing of $920 Million Public Offering
Published on 07/06/2026 at 19:41, 3 hours 15 minutes ago AVANTAGE : Founding shareholders of Voyageurs du Monde announce shareholding reorganisation and proposed Public Tender Offer
Published on 07/06/2026 at 19:41, 3 hours 15 minutes ago AVANTAGE : Les Fondateurs de Voyageurs du Monde annoncent une réorganisation actionnariale et le lancement d'un projet d'offre publique
Published on 07/06/2026 at 18:00, 4 hours 57 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 26 juin 2026
Published on 07/06/2026 at 18:00, 4 hours 57 minutes ago Information concerning the total number of voting rights and shares in the share capital as of June 26, 2026
Published on 07/06/2026 at 18:00, 4 hours 57 minutes ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 30 juin 2026
Published on 07/06/2026 at 17:59, 4 hours 57 minutes ago Acquisition of Xypex in construction chemicals, a leader in high value-added waterproofing solutions
